About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 114 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 114 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 114 trials

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedThe Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)This is a multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by active treatment, to evaluate the efficacy, safety and…NCT01707992·Cullman, Alabama and 283 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

Active not recruitingEvaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and PainThe purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or…NCT07132775·Chicago, Illinois

CompletedEffects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple SclerosisNearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking.NCT06264336·Chicago, Illinois

RecruitingHome Based Functional Balance Intervention for Multiple SclerosisThe study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on…NCT07355387·Chicago, Illinois

TerminatedFeasibility of the Multiple Sclerosis Performance Test in Participants With Multiple SclerosisThe primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis…NCT03926637·Berkeley, California and 32 others

CompletedComparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoThe purpose of this study was to establish the efficacy and safety of two different doses of alemtuzumab (Lemtrada™) as a treatment for relapsing-remitting multiple sclerosis…NCT00548405·Cullman, Alabama and 190 others

CompletedHome Exercise Intervention in Persons With Multiple SclerosisThe objective of this study is to determine the effect of home-based, aerobic exercise training on subclinical atherosclerosis and mobility disability in persons with Multiple…NCT01824550·Chicago, Illinois

RecruitingEffects of Acute Intermittent Hypoxia on Neuroplasticity in MSThis study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population.NCT06390930·Chicago, Illinois

CompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisThe purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting…NCT00030966·Birmingham, Alabama and 87 others

UnknownOptic Neuritis Treatment Trial (ONTT)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000146·Little Rock, Arkansas and 14 others

CompletedTraditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun.NCT03500328·Birmingham, Alabama and 46 others

CompletedStress Management for Patients With Multiple SclerosisThere is a growing body of literature showing that stressful life events can increase the risk of developing exacerbations and new brain lesions among people with multiple…NCT00147446·San Francisco, California and 2 others

CompletedSafety and Efficacy of AVP-923 in PBA Patients With ALS or MSObjectives of the study are to evaluate the safety, tolerability, and efficacy of two different doses of AVP-923 (capsules containing either 30 mg of dextromethorphan hydrobromide…NCT00573443·Phoenix, Arizona and 61 others

CompletedSafety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple SclerosisThe purpose of this study was to determine the dose-response curve for the MRI-based efficacy of BAF312 compared with placebo in patients with Relapsing-Remitting Multiple…NCT00879658·Cullman, Alabama and 71 others

TerminatedAn Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)This study will investigate the efficacy, safety and tolerability of a new formulation of glatiramer acetate administered at 20 mg/0.5 ml daily versus placebo in patients with…NCT01578785·Cullman, Alabama and 168 others

RecruitingPeople With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 AgonistsThe primary outcome measure is PIRA (progression independent of relapse activity), based primarily on clinical assessment, dichotomized as present or not.NCT07207148·Chicago, Illinois

Active not recruitingOcrelizumab Discontinuation in Relapsing Multiple SclerosisThis study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS.NCT05285891·New Haven, Connecticut and 12 others

TerminatedFeasibility of Remote Exercise Training for Hispanics/Latinos With MSThe goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS).NCT05998616·Chicago, Illinois

PreviousPage 2 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia